https://www.marketscreener.com/quote/stock/SANOFI-4698/news/Sanofi-European-Commission-approves-Aubagio-teriflunomide-as-the-first-oral-MS-therapy-for-fir-35701506/?utm_source=telegram&utm_medium=social&utm_campaign=share